Cargando…
Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
PURPOSE: Since tumor mutational burden (TMB) and gene expression profiling (GEP) have complementary effects, they may have improved predictive power when used in combination. Here, we investigated the ability of TMB and GEP to predict the immunotherapy response in patients with non–small cell lung c...
Autores principales: | Kim, Hyojin, Kwon, Hyun Jung, Kim, Eun Sun, Kwon, Soohyeon, Suh, Kyoung Jin, Kim, Se Hyun, Kim, Yu Jung, Lee, Jong Seok, Chung, Jin-Haeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016300/ https://www.ncbi.nlm.nih.gov/pubmed/34237208 http://dx.doi.org/10.4143/crt.2021.583 |
Ejemplares similares
-
Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma
por: Kwon, Soohyeon, et al.
Publicado: (2020) -
Clinical validity of oncogenic driver genes detected from circulating tumor DNA in the blood of lung cancer patients
por: Kim, Sheehyun, et al.
Publicado: (2023) -
PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
por: Kim, Hyojin, et al.
Publicado: (2017) -
Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer
por: Park, Sehhoon, et al.
Publicado: (2022) -
Osteosarcomatous Differentiation in Rebiopsy Specimens of Pulmonary Adenocarcinoma with EGFR-TKI Resistance
por: Ahn, Hyein, et al.
Publicado: (2018)